Copyright
©The Author(s) 2024.
World J Hepatol. Mar 27, 2024; 16(3): 366-378
Published online Mar 27, 2024. doi: 10.4254/wjh.v16.i3.366
Published online Mar 27, 2024. doi: 10.4254/wjh.v16.i3.366
Genetic polymorphisms | Lipid parameters | |||||||
Triglyceride (mg/dL), (n = 177) | Total cholesterol (mg/dL), (n = 177) | LDL-cholesterol (mg/dL), (n = 177) | HDL-cholesterol (mg/dL), (n = 66) | HDL-cholesterol (mg/dL), (n = 111) | ||||
< 150 | ≥ 150 | < 200 | ≥ 200 | < 130 | ≥ 130 | Men ≥ 40 mg/dL, women ≥ 50 mg/dL | Men < 40 mg/dL, women < 50 mg/dL | |
PNPLA3 rs738409 CC vs CG+GG | ||||||||
OR (95%CI) | 0.699 (0.383-1.277) | 1.053 (0.580-1.912) | 1.088 (0.597-1.981) | 0.9967 (0.538 -1.846) | ||||
P value | 0.243 | 0.865 | 0.784 | 0.992 | ||||
APOC3 rs2854116 TT vs CT+CC | ||||||||
OR (95%CI) | 0.796 (0.387-1.635) | 1.611 (0.780-3.328) | 1.173 (0.568-2.423) | 0.4696 (0.253-0.873) | ||||
P value | 0.534 | 0.195 | 0.666 | 0.017a | ||||
APOA5 rs662799 AA vs AG+GG | ||||||||
OR (95%CI) | 1.021 (0.562-1.855) | 0.543 (0.299-0.989) | 0.595 (0.326-1.084) | 0.739 (0.374-1.461) | ||||
P value | 0.946 | 0.045a | 0.089 | 0.385 | ||||
APOB rs10495712 (GG vs AG+AA) | ||||||||
OR (95%CI) | 0.749 (0.322-1.743) | 0.719 (0.315-1.639) | 0.807 (0.351-1.855) | 0.816 (0.343-1.938) | ||||
P value | 0.501 | 0.431 | 0.613 | 0.645 | ||||
LIPC rs1800588 CC vs CT+TT | ||||||||
OR (95%CI) | 0.870 (0.467-1.621) | 0.732 (0.393-1.363) | 0.607 (0.326-1.132) | 0.911 (0.482-1.722) | ||||
P value | 0.661 | 0.325 | 0.115 | 0.774 | ||||
LEP rs7799039 GG vs AG+AA | ||||||||
OR (95%CI) | 9.316 (2.064-40.428) | 1.623 (0.655-4.017) | 1.518 (0.602-3.825) | 1.317 (0.507-3.419) | ||||
P value | 0.001a | 0.292 | 0.374 | 0.572 | ||||
GHRL rs27647 (AA vs AG+GG) | ||||||||
OR (95%CI) | 0.570 (0.265-1.224) | 0.997 (0.483-2.058) | 0.905 (0.436-1.878) | 0.889 (0.417-1.895) | ||||
P value | 0.147 | 0.993 | 0.788 | 0.761 |
- Citation: Choochuay K, Kunhapan P, Puangpetch A, Tongsima S, Srisawasdi P, Sobhonslidsuk A, Sungkanuparph S, Biswas M, Sukasem C. Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus. World J Hepatol 2024; 16(3): 366-378
- URL: https://www.wjgnet.com/1948-5182/full/v16/i3/366.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i3.366